Brii Biosciences Ltd (HKSE:02137)
HK$ 1.09 0 (0%) Market Cap: 795.53 Mil Enterprise Value: -2.06 Bil PE Ratio: 0 PB Ratio: 0.23 GF Score: 19/100

Brii Biosciences Ltd AASLD Data Readout Investor Call Transcript

Nov 14, 2023 / 12:00AM GMT
Release Date Price: HK$2.72
Sarah Qiu

Good morning, good evening, everyone. Thank you for joining our AASLD Data Readout Investor Call today. Before we start, I would like to remind you that statements made during this call may include forward-looking statements. The company is not obligated to update these statements based on new information or events. This is Sarah Qiu, Associate Director of Investor Relations.

On today's call from Brii Bio's executive management team, we have Dr. Zhi Hong Chairman and Chief Executive Officer. Dr. David Margolis, Chief Medical Officer; Dr. Qing Zhu, Head of China R&D; and Dr. Ankang Li, Chief Strategy and Financial Officer. Dr. Hong will provide opening remarks, followed by Dr. Margolis discussing our AASLD presentation. Dr. Zhu and Dr. Li will join the Q&A after the prepared remarks. And finally, Dr. Hong will close with final remarks. Now I would like to turn the call over to our CEO, Dr. Hong. Please go ahead.

Zhi Hong
Brii Biosciences Limited - Co-founder, Executive Chairman of the Board & CEO

Well, thank you, Sarah. Good morning,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot